We are live on
!
Find out more
NWP
Northstar Wealth Partners Portfolio holdings
AUM
$215M
1-Year Est. Return
12.82%
This Fund
S&P 500
This Quarter
Est. Return
+7.58%
1 Year Est. Return
+12.82%
3 Year Est. Return
+36.23%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$244M
AUM Growth
+$16.2M
(+7.1%)
Cap. Flow
+$495K
Cap. Flow
% of AUM
0.2%
Top 10 Holdings %
Top 10 Hldgs %
23.92%
Holding
186
New
9
Increased
70
Reduced
67
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.67M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$1.09M |
| 3 |
Vanguard High Dividend Yield ETF
VYM
|
+$660K |
| 4 |
First Trust Value Line Dividend Fund
FVD
|
+$274K |
| 5 |
Equinix
EQIX
|
+$260K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.46M |
| 2 |
CELG
Celgene Corp
CELG
|
+$787K |
| 3 |
Boston Scientific
BSX
|
+$566K |
| 4 |
Gabelli Equity Trust
GAB
|
+$397K |
| 5 |
Visa
V
|
+$321K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.89% |
| 2 | Industrials | 12.62% |
| 3 | Healthcare | 12.24% |
| 4 | Consumer Staples | 11.3% |
| 5 | Communication Services | 5.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
iShares MSCI USA Momentum Factor ETF
MTUM
$26.5B
| $209K | 0.09% |
+1,672
| New | +$203K |
|
177
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$6.92B
| $208K | 0.09% |
1,902
+2
| +0.1% | +$217 |
|
178
Nuveen AMT-Free Quality Municipal Income Fund
NEA
$3.39B
| $205K | 0.08% |
+14,320
| New | +$203K |
|
179
Invesco Water Resources ETF
PHO
$2.06B
| $204K | 0.08% |
+5,305
| New | +$197K |
|
180
State Street DoubleLine Total Return Tactical ETF
TOTL
$4.02B
| $204K | 0.08% |
+4,178
| New | +$205K |
|
|
MMT
181
Aberdeen Multi-Market Income Fund
MMT
$239M
| $192K | 0.08% |
31,416
+38
| +0.1% | +$229 |
|
182
Ford
F
$56.5B
| $173K | 0.07% |
18,679
+280
| +2% | +$2.52K |
|
|
HIO
183
Western Asset High Income Opportunity Fund
HIO
$339M
| $95K | 0.04% |
18,800
| – | – |
|
|
184
Boston Scientific
BSX
$70.5B
| – | – |
-11,171
| Closed | -$566K |
|
185
JPMorgan Ultra-Short Income ETF
JPST
$40.3B
| – | – |
-4,945
| Closed | -$249K |
|
|
CELG
186
DELISTED
Celgene Corp
CELG
| – | – |
-7,925
| Closed | -$787K |
|
Similar funds
AIMH
CWM
LFG
RA
SAM
RGIA
WR
SCM
Northstar Wealth Partners's Q4 2019 Portfolio in Review
As of Q4 2019, Northstar Wealth Partners held 186 positions worth $244M, up 7.1% from $228M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Northstar Wealth Partners's Q4 2019 filing shows 9 new, 70 increased, 67 reduced and 3 closed positions. Its largest new stake was Bristol-Myers Squibb: 19,070 shares worth $1.22M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.46M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Industrials and Healthcare.
- Northstar Wealth Partners's largest Q4 2019 buy was Bristol-Myers Squibb: 19,070 shares worth $1.22M.
- Northstar Wealth Partners added most to Pfizer in Q4 2019, an estimated $1.67M increase.
- Northstar Wealth Partners's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.46M.
- Northstar Wealth Partners fully exited Celgene Corp in Q4 2019, selling an estimated $787K.
- Northstar Wealth Partners's ten largest holdings make up 24% of its $244M portfolio in Q4 2019.
- Northstar Wealth Partners opened 9 new positions and closed 3 in Q4 2019.
- Northstar Wealth Partners's portfolio value rose 7.1% quarter-over-quarter to $244M.
Based on Northstar Wealth Partners's 13F filing for Q4 2019, filed 13 Feb 2020.